Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
2005 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
Management of Stroke in Infants and Children
2008
The FGF family: biology, pathophysiology and therapy
2009 Standout
Clinical translation of angiogenesis inhibitors
2002 Standout
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
2005
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
VEGF targets the tumour cell
2013
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
Drug development from marine natural products
2008 Standout
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
The biology of VEGF and its receptors
2003 Standout
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Anti-angiogenic activity of inositol hexaphosphate (IP6)
2004
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4
2003
Putting tumours in context
2001 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Extracellular matrix structure
2015 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Biology and management of relapsed acute myeloid leukaemia
2005
Unfulfilled Promise of Endostatin in a Gene Therapy-Xenotransplant Model of Human Acute Lymphocytic Leukemia
2002
Prevention of Venous Thromboembolism
2004 Standout
Sickle-cell disease
2010 Standout
The role of VEGF in normal and neoplastic hematopoiesis
2002
Capturing complex 3D tissue physiology in vitro
2006 Standout
Prevention of Venous Thromboembolism
2008 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
2017 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Chemotherapy-induced thrombosis
2006
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Breast cancer metastasis: markers and models
2005 Standout
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Activation of Vascular Endothelial Growth Factor Receptor-2 in Bone Marrow Leads to Accumulation of Myeloid Cells: Role of Granulocyte-Macrophage Colony-Stimulating Factor
2005
Risk Factors for Arterial Ischemic Stroke in Children
2000
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells
2005 Standout
Global gene expression of cells attached to a tissue engineering scaffold
2004 StandoutNobel
VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia
2004
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
The extracellular matrix at a glance
2010 Standout
Mechanisms of Plaque Formation and Rupture
2014 Standout
After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies
2004
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias
2001
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Clinical Implications of Circulating Angiogenic Factors in Cancer Patients
2001
Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia
2005
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease
2005
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma.
2001
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
2003
A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia
2003
Plasmin Promotes Foam Cell Formation by Increasing Macrophage Catabolism of Aggregated Low-Density Lipoprotein
2013
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications
2002 Standout
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Autocrine/Paracrine Mechanisms in Human Hematopoiesis
2001
Works of Sandra Ruíz being referenced
Fatal haemorrhagic infarct in an infant with homocystinuria
1999
Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions
2004
Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia
2002
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
2000
Fatal haemorrhagic infarct in an infant with homocystinuria
1999
Efficacy and safety of thalidomide in patients with acute myeloid leukemia
2002